 In the Center for Clinical Research, we conduct several stem cell studies. For the last 20 years, Texas Heart Institute has been studying the use of cell therapy to treat cardiovascular disease with a primary focus on heart failure. Another approach involves using gene therapy to promote cardiomyocyte replication. Many studies are being performed utilizing bone marrow cells, both autologous, which means from the individual receiving the cells, and allogeneic from the other individual cells. Imagine if you could use cells from a younger donor that naturally self-renew to deliver a potent cell therapy. Cell-based therapies for heart failure have entered an exciting new era, and we at the Center for Clinical Research are excited with the trials underway.